224 related articles for article (PubMed ID: 26850997)
21. Patterns of neutrophil serine protease-dependent cleavage of surfactant protein D in inflammatory lung disease.
Cooley J; McDonald B; Accurso FJ; Crouch EC; Remold-O'Donnell E
J Leukoc Biol; 2008 Apr; 83(4):946-55. PubMed ID: 18211966
[TBL] [Abstract][Full Text] [Related]
22. Discriminating between the activities of human neutrophil elastase and proteinase 3 using serpin-derived fluorogenic substrates.
Korkmaz B; Attucci S; Hazouard E; Ferrandiere M; Jourdan ML; Brillard-Bourdet M; Juliano L; Gauthier F
J Biol Chem; 2002 Oct; 277(42):39074-81. PubMed ID: 12114510
[TBL] [Abstract][Full Text] [Related]
23. Targeted Library of Phosphonic-Type Inhibitors of Human Neutrophil Elastase.
Torzyk-Jurowska K; Ciekot J; Winiarski L
Molecules; 2024 Mar; 29(5):. PubMed ID: 38474630
[TBL] [Abstract][Full Text] [Related]
24. The Role of Serine Proteases and Antiproteases in the Cystic Fibrosis Lung.
Twigg MS; Brockbank S; Lowry P; FitzGerald SP; Taggart C; Weldon S
Mediators Inflamm; 2015; 2015():293053. PubMed ID: 26185359
[TBL] [Abstract][Full Text] [Related]
25. Lung tissue destruction by proteinase 3 and cathepsin G mediated elastin degradation is elevated in chronic obstructive pulmonary disease.
Gudmann NS; Manon-Jensen T; Sand JMB; Diefenbach C; Sun S; Danielsen A; Karsdal MA; Leeming DJ
Biochem Biophys Res Commun; 2018 Sep; 503(3):1284-1290. PubMed ID: 30017196
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of the activation of multiple serine proteases with a cathepsin C inhibitor requires sustained exposure to prevent pro-enzyme processing.
Méthot N; Rubin J; Guay D; Beaulieu C; Ethier D; Reddy TJ; Riendeau D; Percival MD
J Biol Chem; 2007 Jul; 282(29):20836-46. PubMed ID: 17535802
[TBL] [Abstract][Full Text] [Related]
27. Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions.
Korkmaz B; Moreau T; Gauthier F
Biochimie; 2008 Feb; 90(2):227-42. PubMed ID: 18021746
[TBL] [Abstract][Full Text] [Related]
28. Kinetics of the inhibition of neutrophil proteinases by recombinant elafin and pre-elafin (trappin-2) expressed in Pichia pastoris.
Zani ML; Nobar SM; Lacour SA; Lemoine S; Boudier C; Bieth JG; Moreau T
Eur J Biochem; 2004 Jun; 271(12):2370-8. PubMed ID: 15182352
[TBL] [Abstract][Full Text] [Related]
29. Proteinase 3; a potential target in chronic obstructive pulmonary disease and other chronic inflammatory diseases.
Crisford H; Sapey E; Stockley RA
Respir Res; 2018 Sep; 19(1):180. PubMed ID: 30236095
[TBL] [Abstract][Full Text] [Related]
30. The Role of Neutrophil Elastase Inhibitors in Lung Diseases.
Polverino E; Rosales-Mayor E; Dale GE; Dembowsky K; Torres A
Chest; 2017 Aug; 152(2):249-262. PubMed ID: 28442313
[TBL] [Abstract][Full Text] [Related]
31. EPI-hNE4, a proteolysis-resistant inhibitor of human neutrophil elastase and potential anti-inflammatory drug for treating cystic fibrosis.
Attucci S; Gauthier A; Korkmaz B; Delépine P; Martino MF; Saudubray F; Diot P; Gauthier F
J Pharmacol Exp Ther; 2006 Aug; 318(2):803-9. PubMed ID: 16627747
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor.
Wright CD; Kennedy JA; Zitnik RJ; Kashem MA
Biochem Biophys Res Commun; 1999 Jan; 254(3):614-7. PubMed ID: 9920787
[TBL] [Abstract][Full Text] [Related]
33. Oxidized elafin and trappin poorly inhibit the elastolytic activity of neutrophil elastase and proteinase 3.
Nobar SM; Zani ML; Boudier C; Moreau T; Bieth JG
FEBS J; 2005 Nov; 272(22):5883-93. PubMed ID: 16279952
[TBL] [Abstract][Full Text] [Related]
34. Measuring elastase, proteinase 3 and cathepsin G activities at the surface of human neutrophils with fluorescence resonance energy transfer substrates.
Korkmaz B; Attucci S; Juliano MA; Kalupov T; Jourdan ML; Juliano L; Gauthier F
Nat Protoc; 2008; 3(6):991-1000. PubMed ID: 18536646
[TBL] [Abstract][Full Text] [Related]
35. Relevance of the mouse model as a therapeutic approach for neutrophil proteinase 3-associated human diseases.
Korkmaz B; Jenne DE; Gauthier F
Int Immunopharmacol; 2013 Dec; 17(4):1198-205. PubMed ID: 23886601
[TBL] [Abstract][Full Text] [Related]
36. Cleavage of the CD11b extracellular domain by the leukocyte serprocidins is critical for neutrophil detachment during chemotaxis.
Zen K; Guo YL; Li LM; Bian Z; Zhang CY; Liu Y
Blood; 2011 May; 117(18):4885-94. PubMed ID: 21403131
[TBL] [Abstract][Full Text] [Related]
37. Effect of DNase on the activity of neutrophil elastase, cathepsin G and proteinase 3 in the presence of DNA.
Duranton J; Belorgey D; Carrère J; Donato L; Moritz T; Bieth JG
FEBS Lett; 2000 May; 473(2):154-6. PubMed ID: 10812064
[TBL] [Abstract][Full Text] [Related]
38. Freezing the Bioactive Conformation to Boost Potency: The Identification of BAY 85-8501, a Selective and Potent Inhibitor of Human Neutrophil Elastase for Pulmonary Diseases.
von Nussbaum F; Li VM; Allerheiligen S; Anlauf S; Bärfacker L; Bechem M; Delbeck M; Fitzgerald MF; Gerisch M; Gielen-Haertwig H; Haning H; Karthaus D; Lang D; Lustig K; Meibom D; Mittendorf J; Rosentreter U; Schäfer M; Schäfer S; Schamberger J; Telan LA; Tersteegen A
ChemMedChem; 2015 Jul; 10(7):1163-73. PubMed ID: 26083237
[TBL] [Abstract][Full Text] [Related]
39. Elafin and its precursor trappin-2 still inhibit neutrophil serine proteinases when they are covalently bound to extracellular matrix proteins by tissue transglutaminase.
Guyot N; Zani ML; Maurel MC; Dallet-Choisy S; Moreau T
Biochemistry; 2005 Nov; 44(47):15610-8. PubMed ID: 16300411
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of neutrophil cathepsin G by oxidized mucus proteinase inhibitor. Effect of heparin.
Boudier C; Cadène M; Bieth JG
Biochemistry; 1999 Jun; 38(26):8451-7. PubMed ID: 10387091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
